Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
10 papers
Recent·Most cited
M. Seyedsadr, M. Bang, E. McCarthy, S. Zhang, H.-C. Chen, M. Mohebbi, W. HUGO, J. K. Whitmire, M. G. Lechner, M. Su
The paper identifies IL-21-expressing CD4+ T cells in an inflammatory neuropathy mouse model and shows their role in neuropathy development through clonal expansion and CXCR6-mediated infiltration.
bioRxiv · Jan 7, 2024Immunology
J. I. Moliva, S. F. Andrew, B. J. Flynn, D. A. Wagner, K. E. Foulds, M. Gagne, D. R. Flebbe, E. Lamb, S. Provost, J. Marquez, A. Mychalowych, C. Lorag, C. C. Honeycutt, M. R. Burnett, L. McCormick, , Nason
This study shows a gorilla adenovirus-based vaccine provides durable immunity against SARS-CoV-2 in both airways of non-human primates, with enhanced protection from aerosol delivery and prime-boost regimens.
bioRxiv · Nov 22, 2023 · PreprintImmunology
M. Gagne, B. J. Flynn, C. C. Honeycutt, D. R. Flebbe, S. F. Andrew, S. J. Provost, L. McCormick, A. Van Ry, E. McCarthy, J.-P. M. Todd, S. Bao, I.-T. Teng, S. Marciano, Y. Rudich, C. Li, , D. C. Douek
RBD-62, a high-affinity ACE2 antagonist, limits SARS-CoV-2 replication in both upper and lower airways in rhesus macaques without blocking memory responses or causing anti-drug immunity.
bioRxiv · Jun 9, 2023 · PreprintImmunology
A. Pitea, R. Turnham, M. Eckhardt, G. M. Jang, Z. Xu, H. C. Lim, A. Choi, J. Von Dollen, R. S. Levin, J. T. Webber, E. McCarthy, J. Hu, X. Li, L. Che, G. Chan, , J. Gordan
This study identifies how HBV alters PP2A complexes to drive liver cancer signaling, revealing potential therapeutic targets.
bioRxiv · Mar 15, 2023 · PreprintCancer Biology
M. Gagne, J. I. Moliva, K. E. Foulds, S. F. Andrew, B. J. Flynn, A. P. Werner, D. A. Wagner, I.-T. Teng, B. C. Lin, C. Moore, N. Jean-Baptiste, R. Carroll, S. L. Foster, M. Patel, M. Ellis, , Naisan
This study compares B cell responses and protection against Omicron after boosting vaccinated macaques with mRNA-1273 or mRNA-Omicron vaccines, finding comparable immunity and protection.
bioRxiv · Feb 3, 2022 · PreprintImmunology
J. F. Ashouri, E. McCarthy, S. Yu, N. Perlmutter, C. Lin, J. DeRisi, C. J. Ye, A. Weiss
This study identifies a defect in anergy and a biased TCR repertoire in naive arthritogenic SKG CD4 T cells, driven by endogenous viral superantigens, leading to autoimmune arthritis.
bioRxiv · Jan 13, 2022 · PreprintImmunology
D. D. Brauer, C. B. Santiago, Z. N. Merz, E. McCarthy, D. Tullman-Ercek, M. B. Francis
The paper generates fitness landscapes for two VLP capsid geometries and uses them to train machine learning models for predicting mutational effects on assembly.
bioRxiv · Dec 21, 2021 · PreprintBioengineering
M. Gagne, K. S. Corbett, B. J. Flynn, K. E. Foulds, D. A. Wagner, S. F. Andrew, J.-P. M. Todd, C. C. Honeycutt, L. McCormick, S. T. Nurmukhambetova, M. E. Davis-Gardner, L. Pessaint, K. W. Bock, B. M. Nagata, M. Minai, , B. S. Graham
This study shows that mRNA-1273 vaccine protection against SARS-CoV-2 Delta in nonhuman primates persists for one year but is delayed and relies on anamnestic antibody responses in the lower airway.
bioRxiv · Oct 23, 2021 · PreprintImmunology
J. R. Francica, B. J. Flynn, K. E. Foulds, A. T. Noe, A. P. Werner, I. N. Morre, M. Gagne, T. S. Johnston, C. Tucker, R. L. Davis, B. Flach, S. O'Connell, S. F. Andrew, E. Lamb, D. R. Flebbe, , McDermott
This study shows that an AS03-adjuvanted SARS-CoV-2 spike protein vaccine induces strong antibody responses and protects nonhuman primates from viral challenge.
bioRxiv · Mar 2, 2021 · PreprintImmunology
F. Collin, Y. Ning, T. Phillips, E. McCarthy, A. Scott, C. Ellison, C.-J. Ku, G. D. Guler, K. Chau, A. Ashworth, S. R. Quake, S. Levy
This study identifies 5-hydroxymethylcytosine (5hmC) signatures in circulating cell-free DNA to detect early-stage pancreatic cancer with high accuracy.
bioRxiv · Sep 26, 2018Cancer Biology